Approval · Notice of Compliance 9529 · 2008
ERWINASE: Notice of Compliance 9529
Issued April 30, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9529
- Date
- April 30, 2008
- Company
- Eusa Pharma SasLanghorne, Pennsylvania, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Cytostatic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ERWINASE | 02237815 | Cancelled Post Market |
Medicinal ingredients
- ASPARAGINASE 10,000 UNIT per VIAL